Published in Am J Public Health on September 01, 1986
Treatment of giardiasis. Clin Microbiol Rev (2001) 2.66
The biology of Giardia spp. Microbiol Rev (1991) 2.28
Giardia--diagnosis, clinical course and epidemiology. A review. Epidemiol Infect (1992) 1.59
Parasitic Infections among Children under Five Years in Senegal: Prevalence and Effect on Anaemia and Nutritional Status. ISRN Parasitol (2013) 0.82
Post epidemic giardiasis and gastrointestinal symptoms among preschool children in Bergen, Norway. A cross-sectional study. BMC Public Health (2010) 0.77
From Leningrad to the day-care center. The ubiquitous Giardia lamblia. West J Med (1990) 0.77
Giardiasis outbreaks in the United States, 1971-2011. Epidemiol Infect (2016) 0.75
The experimental transmission of human intestinal protozoan parasites. II. Giardia lamblia cysts given in capsules. Am J Hyg (1954) 4.65
Handwashing to prevent diarrhea in day-care centers. Am J Epidemiol (1981) 3.75
Epidemic giardiasis at a ski resort. N Engl J Med (1969) 3.73
Giardiasis in day-care centers: evidence of person-to-person transmission. Pediatrics (1977) 3.06
An outbreak of foodborne giardiasis. N Engl J Med (1981) 2.98
Municipal waterborne giardiasis: an epidemilogic investigation. Beavers implicated as a possible reservoir. Ann Intern Med (1980) 2.69
Giardiasis. Pediatr Clin North Am (1979) 2.56
Giardiasis in American travelers to the Soviet Union. J Infect Dis (1974) 2.36
Diarrhea caused by Shigella, rotavirus, and Giardia in day-care centers: prospective study. J Pediatr (1981) 2.21
Venereal transmission of enteric pathogens in male homosexuals. Two case reports. JAMA (1977) 2.13
An outbreak of giardiasis in a group of campers. Am J Trop Med Hyg (1976) 2.04
Person-to-person transmission of Giardia lamblia in day-care nurseries. Can Med Assoc J (1978) 1.97
Waterborne giardiasis: a communitywide outbreak of disease and a high rate of asymptomatic infection. Am J Epidemiol (1980) 1.89
Giardia lamblia infection in homosexual men. Br J Vener Dis (1977) 1.65
Giardiasis in travelers. J Infect Dis (1971) 1.64
Parasitic infections in a closed community. Results of a 10-year survey in Willowbrook State School. Trans R Soc Trop Med Hyg (1972) 1.35
Parasitic disease control in a residential facility for the mentally retarded. Am J Public Health (1979) 1.30
Giardiasis in Colorado: an epidemiologic study. Am J Epidemiol (1977) 1.29
Endemic giardiasis and day care. Pediatrics (1983) 1.12
Comparative study of stool examinations, duodenal aspiration, and pediatric Entero-Test for giardiasis in children. J Pediatr (1980) 1.00
Waterborne giardiasis. Ann Intern Med (1974) 0.93
Changes in thymic function with age and during the treatment of HIV infection. Nature (1998) 10.27
Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med (1997) 5.88
A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N Engl J Med (1979) 5.87
Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med (1992) 5.84
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc Natl Acad Sci U S A (1999) 5.25
Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med (1985) 4.25
Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study. N Engl J Med (1995) 4.06
An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test. Am J Epidemiol (1966) 3.72
Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses. J Clin Microbiol (1981) 3.46
Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science (1988) 3.44
A study of excess mortality during influenza epidemics in the United States, 1968-1976. Am J Epidemiol (1981) 3.27
Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. J Exp Med (2001) 3.05
Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. N Engl J Med (1976) 2.96
Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N Engl J Med (1996) 2.86
A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med (1991) 2.75
Glycophorin B as an EBA-175 independent Plasmodium falciparum receptor of human erythrocytes. Mol Biochem Parasitol (1994) 2.67
Serious infections from Bacillus sp. JAMA (1979) 2.67
Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J Infect Dis (1995) 2.63
A new one-step method for the functional assay of the fourth component (C4) of human and guinea pig complement. J Immunol (1974) 2.60
Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule. Proc Natl Acad Sci U S A (1988) 2.60
Colchicine therapy for familial mediterranean fever. A double-blind trial. N Engl J Med (1974) 2.35
Lack of clinical utility of cytomegalovirus blood and urine cultures in patients with HIV infection. Ann Intern Med (1993) 2.32
Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med (1986) 2.27
Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity. J Virol (1987) 2.26
In vitro activity of rifampin alone and in combination with nafcillin and Vancomycin against pathogenic strains of Staphylococcus aureus. Antimicrob Agents Chemother (1978) 2.21
Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients. Proc Natl Acad Sci U S A (2000) 2.20
Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. A report from the Multicenter AIDS Cohort Study. Ann Intern Med (1988) 2.18
Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection. Blood (2000) 2.15
Teichoic acid serologic diagnosis of staphylococcal endocarditis. Use of gel diffusion and counterimmunoelectrophoretic methods. Ann Intern Med (1975) 2.15
Treatment of chronic mucocutaneous candidiasis with ketoconazole: a controlled clinical trial. Ann Intern Med (1980) 2.14
A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis (1999) 2.14
Microbiologic study of street heroin and injection paraphernalia. J Infect Dis (1974) 2.10
Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. N Engl J Med (1987) 2.05
A comparison of the frequency of hepatitis-B antigen and antibody in hospital and nonhospital personnel. N Engl J Med (1973) 2.05
Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med (1987) 1.89
Staphylococcus aureus bacteremia: relationship between formation of antibodies to teichoic acid and development of metastatic abscesses. J Infect Dis (1978) 1.88
Occurrence, predictors, and consequences of adult asthma in NHANESI and follow-up survey. Am Rev Respir Dis (1989) 1.83
Staphylococcal endocarditis in drug users. Clinical and microbiologic aspects. Arch Intern Med (1975) 1.83
Drug interactions in patients infected with human immunodeficiency virus. Clin Infect Dis (1996) 1.82
An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag. J Virol (1991) 1.80
Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection. J Clin Microbiol (1986) 1.79
Use of the enzyme-linked immunosorbent assay to detect serum antibody responses of volunteers who received attenuated influenza A virus vaccines. Infect Immun (1980) 1.77
Bacillus cereus panophthalmitis: source of the organism. Rev Infect Dis (1982) 1.74
Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study. N Engl J Med (1972) 1.73
Gram-positive pneumonias. Med Clin North Am (1980) 1.64
Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: class prediction analyses before treatment predict the outcome of anti-HCV therapy among HIV-coinfected persons. J Infect Dis (2006) 1.60
Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine. J Immunol (1996) 1.60
A controlled trial of HA-1A in a canine model of gram-negative septic shock. JAMA (1993) 1.59
Toxoplasma encephalitis in patients with acquired immune deficiency syndrome: diagnosis and response to therapy. Am J Trop Med Hyg (1987) 1.56
A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med (2000) 1.55
Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis (1990) 1.49
Predicting the progression to AIDS. Am J Med (1990) 1.49
Teichoic acid antibodies in the diagnosis of serious infections with Staphylococcus aureus. Ann Intern Med (1976) 1.49
Interleukin 2 receptor expression in unstimulated murine splenic T cells. Localization to L3T4+ cells and regulation by non-H-2-linked genes. J Exp Med (1986) 1.44
Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study. J Am Acad Dermatol (1999) 1.43
Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy. Am J Ophthalmol (2000) 1.42
NIH conference. Recent advances in the management of AIDS-related opportunistic infections. Ann Intern Med (1994) 1.42
Kinetics of the antibody response to type III pneumococcal polysaccharide. I. Evidence that suppressor cells function by inhibiting the recruitment and proliferation of antibody-producing cells. J Immunol (1976) 1.42
Use of an X-linked human neutrophil marker to estimate timing of lyonization and size of the dividing stem cell pool. J Clin Invest (1985) 1.41
Clinical and microbiologic aspects of serious infections caused by Staphylococcus epidermidis. Scand J Infect Dis (1983) 1.39
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis. JAMA (1999) 1.38
Detection of endotoxin in cerebrospinal and joint fluids by limulus assay. Arch Intern Med (1977) 1.33
Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (1995) 1.32
Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci. Antimicrob Agents Chemother (1984) 1.28
Determination of influenzavirus neuraminidase inhibition titres. Bull World Health Organ (1975) 1.27
Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial. Ann Intern Med (1993) 1.27
A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection. J Infect Dis (1999) 1.26
Donor transaminase and recipient hepatitis. Impact on blood transfusion services. JAMA (1981) 1.24
Immunologic tolerance in lymphatic filariasis. Diminished parasite-specific T and B lymphocyte precursor frequency in the microfilaremic state. J Clin Invest (1992) 1.24
Increased rate of carriage of Staphylococcus aureus among narcotic addicts. J Infect Dis (1974) 1.24
Quantitation of antibody to hepatitis A antigen by immune electron microscopy. Infect Immun (1976) 1.24
Cyclic hematopoiesis: the mechanism of cyclic neutropenia in grey collie dogs. J Clin Invest (1972) 1.23
A prospective trial of colchicine for primary biliary cirrhosis. N Engl J Med (1986) 1.22
Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression. AIDS (2000) 1.22
Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults. Nat Med (1998) 1.21
Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy. Eur J Immunol (2001) 1.20
Immunogenicity and reactogenicity of influenza A/New Jersey/76 virus vaccines in normal adults. J Infect Dis (1977) 1.16
Reversibility of the pathological changes in the follicular dendritic cell network with treatment of HIV-1 infection. Proc Natl Acad Sci U S A (1999) 1.16
Frequency of variant antigens in Giardia lamblia. Exp Parasitol (1990) 1.16
Neutropenia probably resulting from nafcillin. JAMA (1975) 1.15
Tuberculous liver abscess. Tubercle (1984) 1.15
Cardiovascular and bacteremic manifestations of Campylobacter fetus infection: case report and review. Rev Infect Dis (1990) 1.14
Evidence for the secretion of soluble peptidoglycans by clinical isolates of Staphylococcus aureus. Infect Immun (1982) 1.11
Vancomycin-associated thrombocytopenia: case report and review of the literature. Am J Hematol (1999) 1.11
Antibiotic susceptibility and synergy of clinical isolates of Listeria monocytogenes. Antimicrob Agents Chemother (1982) 1.10
In vitro correlation of platelet aggregation with occurrence of disseminated intravascular coagulation and subacute bacterial endocarditis. J Lab Clin Med (1987) 1.10
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Arch Intern Med (1998) 1.09
Human immunodeficiency virus (HIV) infection in older people: a case report. J Am Geriatr Soc (1998) 1.09
Staphylococcal septicemia and disseminated intravascular coagulation. Staphylococcus aureus endocarditis mimicking meningococcemia. Arch Intern Med (1977) 1.09
Antibody levels to bacterial peptidoglycan in human sera during the time course of endocarditis and bacteremic infections caused by Staphylococcus aureus. Infect Immun (1981) 1.09
Infectivity of visna virus DNA. Virology (1976) 1.09
Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Standard percutaneous revaccination of children who receive primary percutaneous vaccination. J Infect Dis (1977) 1.08
Inhibition of immunoreactive tumor necrosis factor-alpha by a chimeric antibody in patients infected with human immunodeficiency virus type 1. J Infect Dis (1996) 1.08
Adverse reactions to methicillin and nafcillin during treatment of serious Staphylococcus aureaus infections. Arch Intern Med (1978) 1.08
Molecular strain typing of Mycobacterium tuberculosis complex in Bamako, Mali. Int J Tuberc Lung Dis (2012) 1.08
Fascioliasis: case reports and review. Clin Infect Dis (1993) 1.08
A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology (1992) 1.08
Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected persons. J Infect Dis (1997) 1.08